This inventor holds 3 USPTO granted patents. Top assignee: Novartis Ag. Active years: 2003-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hésingue, FR (2003)
- Hesingue, FR (2004)
- Wyoming, OH (US) (2010)
Company Filing History:
Years Active: 2003-2010
Title: Innovations and Contributions of Inventor George Thomas
Introduction
George Thomas is an accomplished inventor based in Hesingue, France. He has made significant contributions to the field of biotechnology, particularly in the study of cancer treatment and cellular mechanisms. With a total of 3 patents, his work has garnered attention for its potential impact on therapeutic strategies.
Latest Patents
One of George Thomas's latest patents is titled "p53 wild-type as biomarker for the treatment with mTOR inhibitors in combination with a cytotoxic agent." This invention provides biomarkers that help determine the sensitivity of proliferative diseases, such as cancer, to therapeutic agents. Specifically, it focuses on mTOR inhibitors used in conjunction with cytotoxic agents that affect DNA integrity.
Another notable patent is related to "Drosophila melanogaster p70 S6 kinase." This invention offers insights into p70, including nucleic acids that encode this kinase. The patent details the sequence of p70 and the gene encoding it, represented in SEQ ID No. 2 and 1, respectively. Additionally, it provides mutated forms of p70, which are useful for studying p70 activity, along with expression systems that produce p70 in various organisms.
Career Highlights
George Thomas is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to explore innovative solutions in the realm of pharmaceuticals and biotechnology. His research has the potential to advance treatment options for patients suffering from various proliferative diseases.
Collaborations
George has collaborated with notable colleagues, including Mary Stewart and Sara Kozma. These partnerships have fostered a collaborative environment that enhances the research and development of groundbreaking therapeutic strategies.
Conclusion
In summary, George Thomas is a prominent inventor whose work in biotechnology has led to significant advancements in cancer treatment and cellular research. His patents reflect a commitment to innovation and a desire to improve therapeutic outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile